<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02890641</url>
  </required_header>
  <id_info>
    <org_study_id>GDR_2015_15</org_study_id>
    <nct_id>NCT02890641</nct_id>
  </id_info>
  <brief_title>Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies</brief_title>
  <acronym>GENEPHY</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      Brain somatic mutations in genes belonging to the mTOR pathway are well recognized in
      malformations of the cortical development, such as focal cortical dysplasia or
      hemimegalencephaly. The present study aims to search for brain somatic mutations in paired
      blood-brain samples from children undergoing epilepsy surgery at the Rothschild Foundation,
      Paris. Patients and their parents will be recruited to identify genetic abnormalities both in
      lymphocytic and cortical DNA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 12, 2015</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>qualitative genetic analysis</measure>
    <time_frame>baseline</time_frame>
    <description>presence of genetic abnormalities, either in lymphocytic or in cortical DNA.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Cortical Dysplasia-Focal Epilepsy Syndrome</condition>
  <arm_group>
    <arm_group_label>drug resistant epilepsy</arm_group_label>
    <description>Sequencing of paired blood-brain DNA samples</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Sequencing of paired blood-brain DNA samples</intervention_name>
    <description>Sequencing of paired blood-brain DNA samples to search for genetic abnormalities</description>
    <arm_group_label>drug resistant epilepsy</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      cortical tissu removed from neurosurgical intervention of epilespy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        children with focal drug-resistant epilepsy, undergoing epilepsy surgery,their parents and
        related party
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children with focal drug-resistant epilepsy (Patients with drug-resistant epilepsies,
             patients with hemimegalencephaly, patients with tuberous sclerosis)

          -  parents of these children and adult relatives who have signed informed consent 1) for
             their child's participation (for parents) and 2) for themselves (parents and adult
             relatives)

          -  social security coverage or foreign regime recognized in France

        Exclusion Criteria:

          -  refusal to participate in the study

          -  contraindication to anaesthesia, to MRI or to surgery

          -  no medical insurance coverage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georg DORFMÜLLER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation A de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence Salomon, MD</last_name>
    <phone>+33 1 48 03 64 31</phone>
    <email>lsalomon@fo-rothschild.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mathilde Chipaux, MD</last_name>
    <phone>01 48 03 69 43</phone>
    <email>mchipaux@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschld</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Salomon, MD</last_name>
      <phone>+33 1 48 03 64 31</phone>
      <email>lsalomon@fo-rothschild.fr</email>
    </contact>
    <investigator>
      <last_name>Georg Dorfmüller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphanie Baulac</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://www.nlm.nih.gov/</url>
    <description>Related Info</description>
  </link>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>focal cortical dysplasia</keyword>
  <keyword>malformation of cortical development</keyword>
  <keyword>hemimegalencephaly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Epilepsies, Partial</mesh_term>
    <mesh_term>Malformations of Cortical Development</mesh_term>
    <mesh_term>Epileptic Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

